| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NewAmsterdam Pharma Co N.V. | Chief Strategy and Business Officer | Ordinary Shares | 15,104 | $385,709 | $25.54 | 07 Jan 2025 | Direct |
| NewAmsterdam Pharma Co N.V. | Chief Strategy and Business Officer | Option (right to buy) | 30,000 | 01 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | 01 May 2025 | 1 | $0 | 4 | Chief Strategy and Business Officer | 02 May 2025, 16:56 |
| NAMS | NewAmsterdam Pharma Co N.V. | 07 Jan 2025 | 1 | $0 | 4 | Chief Business Officer | 07 Jan 2025, 17:15 |
| NAMS | NewAmsterdam Pharma Co N.V. | 02 Jan 2025 | 1 | $0 | 4 | Chief Business Officer | 06 Jan 2025, 17:54 |
| NAMS | NewAmsterdam Pharma Co N.V. | 26 Sep 2024 | 1 | +$17,333 | 4 | Chief Business Officer | 30 Sep 2024, 17:22 |
| NAMS | NewAmsterdam Pharma Co N.V. | 01 Apr 2024 | 1 | $0 | 4 | Chief Business Officer | 02 Apr 2024, 16:30 |
| NAMS | NewAmsterdam Pharma Co N.V. | 29 Dec 2023 | 0 | $0 | 3 | Director | 29 Dec 2023, 16:30 |